Anne E. Wojcicki (/wuːˈtʃɪtski/ woo-CHITS-kee;[2] born July 28, 1973) is an American entrepreneur who co-founded and is CEO of the personal genomics company 23andMe.

[6] After graduating, Wojcicki worked as a healthcare consultant at Passport Capital, a San Francisco-based investment fund[6] and Investor AB.

[5] Wojcicki is a member of the Xconomists, an ad hoc team of editorial advisors for the tech news and media company Xconomy.

In approximately 2005, Wojcicki and her then husband Sergey Brin bought at least half a dozen commercial properties in downtown Los Altos.

[16] Under the name of Passerelle Investment Company, they sponsored events and urban planning initiatives throughout the downtown business district.

[18][19] Wojcicki has expressed interest in "revolutioniz[ing] health care" with DNA testing,[18] as it could provide consumers with enough information to predict potential genetic illnesses.

[21] Beginning in 2015, the Food and Drug Administration started to give approval to 23andMe's health-related tests, including risk from cystic fibrosis, sickle cell anemia, certain cancers, Alzheimer's, Parkinson's, and coeliac disease.

[24][18] When Wojcicki took 23andMe public through a merger with a special-purpose acquisition company in 2021, Forbes dubbed her the "newest self-made billionaire.

[37] Her grandmother, Janina Wójcicka Hoskins, was a Polish-American librarian at the Library of Congress who was responsible for building the largest collection of Polish material[clarification needed] in the United States.